3 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow DR. MALA KHAN: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19 COVID-19 | Completed | DR. MALA KHAN | 150 | 2022-06-01 | 2022-09-27 | |
| Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx 0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient, 0.6% PVP-I Oral and nasal spray to asymptomatic to mild COVID-19 patient having multiple comorbidity, 0.6% PVP-I Oral and nasal spray to healthy volunteer - Virus Infection, RNA, Effect of Drug | Phase 3 | Completed | DR. MALA KHAN | 798 | 2021-04-10 | 2022-01-20 |
| Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy Oral Squamous Cell Carcinoma - Oral Squamous Cell Carcinoma | Unknown | DR. MALA KHAN | 110 | 2020-12-15 | 2022-02-22 | |
| Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo Povidone-Iodine 0.4% NI, Povidone-Iodine 0.5% NI, Povidone-Iodine 0.6% NI - COVID19 | Phase 2 | Completed | DR. MALA KHAN | 200 | 2020-07-01 | 2022-01-25 |
COVID-19 (2) · RNA Virus Infections (1) · Squamous Cell Carcinoma of Head and Neck (1)
Control Groups (1) · Povidone-Iodine (1)
Bangladesh (4)
Dr. Dipayan Mojumder, BDS (1) · Mostafa Kamal Arefin, Dr. (1) · Prof Sk Nurul Fattah Rumi, MBBS, MS (1)